SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-22-028496
Filing Date
2022-08-08
Accepted
2022-08-05 21:14:10
Documents
49
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q brhc10040288_10q.htm   iXBRL 10-Q 881324
2 EXHIBIT 31.1 brhc10040288_ex31-1.htm EX-31.1 11509
3 EXHIBIT 31.2 brhc10040288_ex31-2.htm EX-31.2 11557
4 EXHIBIT 32.1 brhc10040288_ex32-1.htm EX-32.1 5160
5 EXHIBIT 32.2 brhc10040288_ex32-2.htm EX-32.2 5174
  Complete submission text file 0001140361-22-028496.txt   4505678

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA aryd-20220630.xsd EX-101.SCH 36464
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aryd-20220630_cal.xml EX-101.CAL 21635
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aryd-20220630_def.xml EX-101.DEF 202990
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aryd-20220630_lab.xml EX-101.LAB 386988
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aryd-20220630_pre.xml EX-101.PRE 261496
43 EXTRACTED XBRL INSTANCE DOCUMENT brhc10040288_10q_htm.xml XML 725684
Mailing Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003
Business Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003 212-284-2300
ARYA Sciences Acquisition Corp IV (Filer) CIK: 0001838821 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40122 | Film No.: 221142195
SIC: 2836 Biological Products, (No Diagnostic Substances)